Lupin Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

01:22 PM, 4th Dec 2025

Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States.